Nucleus RadioPharma

From formulation and clinical manufacturing to scale-up and regulatory support, Nucleus helps biotech companies bring radiotherapies to market.

Nucleus RadioPharma helps pharma companies scale radiotherapy production with reliable manufacturing, isotope supply, and distribution built for continuity.

Four considerations for biotech + pharma organizations entering the radiotherapy manufacturing space, from decision-making to partnerships.

The page covers radiopharmaceuticals, including manufacturing, supply chains, and regulatory strategy.

Jennifer Vogel manages tech transfer, regulatory compliance, and scaling up to meet industry demand.

While some may associate radiopharmaceuticals with recent innovations, clinical use dates back more than 80 years, with the pioneering application of radioactive iodine for thyroid conditions and cancer.

Nucleus RadioPharma is expanding in Rochester, MN, and Pennsylvania, with openings at both facilities.

Nucleus RadioPharma provides CDMO support at each stage to connect radiopharmaceutical innovation with patient access.

Nucleus RadioPharma's team discusses R&D support, clinical manufacturing, commercial production, and partnership opportunities.

Nucleus RadioPharma is an end-to-end CDMO specializing in radiopharmaceutical development, manufacturing, and supply chain solutions — from clinical trials through commercialization.

Nucleus RadioPharma's privacy policy explains how the company collects, uses, and protects personal information.